Literature DB >> 438828

Familial occurrence of moya-moya disease: report of three Japanese families.

T Kitahara, N Ariga, A Yamaura, H Makino, Y Maki.   

Abstract

Three Japanese families with moya-moya disease in six patients are presented. These six patients were among 49 cases of confirmed moya-moya disease in our experience, and the familial incidence was more than 12%. A relatively high familial incidence (7%) was found in the total Japanese series emphasising the important hereditary components in the pathogenesis of the disease.

Entities:  

Mesh：

Year:  1979        PMID： 438828      PMCID： PMC490722          DOI： 10.1136/jnnp.42.3.208

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  5 in total

1.  The Moyamoya syndrome and the neurosurgeon.

Authors:  H A Krayenbühl
Journal:  Surg Neurol       Date:  1975-10

2.  Familial occurrence of bilateral intracranial occlusion of the internal carotid arteries (Moya Moya).

Authors:  I Søgaard; J Jørgensen
Journal:  Acta Neurochir (Wien)       Date:  1975       Impact factor: 2.216

3.  Bilateral temporal-middle cerebral artery anastomosis for Moyamoya syndrome.

Authors:  A R Amine; R A Moody; W Meeks
Journal:  Surg Neurol       Date:  1977-07

4.  [Familial case of progressive and bilateral hypoplasia of branches of the circle of Willis with anatomic examination].

Authors:  E Praud; B Labrune; G Lyon; R Mallet
Journal:  Arch Fr Pediatr       Date:  1972-04

5.  [Study of diseases presenting fibrilla-like vessels at the base of brain (frequently found in the Japanese)].

Authors:  J Suzuki; A Takaku; M Asahi; M Kowada
Journal:  No To Shinkei       Date:  1965-08
  5 in total
  14 in total

Review 1.  Moyamoya disease.

Authors:  M Farrugia; D C Howlett; A M Saks
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 2.  Cerebrovascular occlusive disease in children: a survey.

Authors:  J I Ausman; F G Diaz; S H Ma; M Dujovny; B Sadasivan
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

3.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

Review 4.  Moyamoya disease in childhood: a familial case report.

Authors:  S Soriani; P Scarpa; A Voghenzi; L De Carlo; R Cilio
Journal:  Childs Nerv Syst       Date:  1993-07       Impact factor: 1.475

5.  Adult moyamoya disease.

Authors: 
Journal:  BMJ       Date:  1993-10-02

6.  Familial occurrence of moyamoya disease. Magnetic resonance angiography as a screening test for high-risk subjects.

Authors:  K Houkin; N Tanaka; A Takahashi; H Kamiyama; H Abe; N Kajii
Journal:  Childs Nerv Syst       Date:  1994-09       Impact factor: 1.475

Review 7.  Moyamoya disease.

Authors:  Y Maki; T Enomoto
Journal:  Childs Nerv Syst       Date:  1988-08       Impact factor: 1.475

8.  Chronic low-perfusion state in children with moyamoya disease following revascularization.

Authors:  H Sato; N Sato; N Tamaki; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

9.  Genetic and immunologic analysis on moya-moya.

Authors:  T Kitahara; K Okumura; A Semba; A Yamaura; H Makino
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-11       Impact factor: 10.154

10.  Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease.

Authors:  Dong-Chuan Guo; Christina L Papke; Van Tran-Fadulu; Ellen S Regalado; Nili Avidan; Ralph Jay Johnson; Dong H Kim; Hariyadarshi Pannu; Marcia C Willing; Elizabeth Sparks; Reed E Pyeritz; Michael N Singh; Ronald L Dalman; James C Grotta; Ali J Marian; Eric A Boerwinkle; Lorraine Q Frazier; Scott A LeMaire; Joseph S Coselli; Anthony L Estrera; Hazim J Safi; Sudha Veeraraghavan; Donna M Muzny; David A Wheeler; James T Willerson; Robert K Yu; Sanjay S Shete; Steven E Scherer; C S Raman; L Maximilian Buja; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2009-04-30       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.